QUEBEC CITY, Nov. 5, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (AEZS) (AEZ.TO) (the “Company”), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today reported financial and operating results as at and for the three months ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
